Related references
Note: Only part of the references are listed.Broth Microdilution and Time-Kill Testing of Caspofungin, Voriconazole, Amphotericin B and their Combinations Against Clinical Isolates of Candida krusei
Yasemin Oz et al.
MYCOPATHOLOGIA (2012)
Genotyping and Antifungal Drug Susceptibility of Trichosporon asahii Isolated from Chinese Patients
Zhikuan Xia et al.
MYCOPATHOLOGIA (2012)
Process Analysis of Variables for Standardization of Antifungal Susceptibility Testing of Nonfermentative Yeasts
Oscar Zaragoza et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Current Knowledge of Trichosporon spp. and Trichosporonosis
Arnaldo L. Colombo et al.
CLINICAL MICROBIOLOGY REVIEWS (2011)
Three-Locus Identification, Genotyping, and Antifungal Susceptibilities of Medically Important Trichosporon Species from China
Li-Na Guo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii
Houmin Li et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Genotyping and Antifungal Drug Susceptibility of the Pathogenic Yeast Trichosporon asahii Isolated from Thai Patients
Nanthawan Mekha et al.
MYCOPATHOLOGIA (2010)
Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients
Ayse Kalkanci et al.
MEDICAL MYCOLOGY (2010)
Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole at Steady State in Healthy Subjects
John E. Conte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species
George R. Thompson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Molecular Identification and Susceptibility of Trichosporon Species Isolated from Clinical Specimens in Qatar: Isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp nov.
Saad J. Taj-Aldeen et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Bloodstream Infections Due to Trichosporon spp.: Species Distribution, Trichosporon asahii Genotypes Determined on the Basis of Ribosomal DNA Intergenic Spacer 1 Sequencing, and Antifungal Susceptibility Testing
Thomas C. Chagas-Neto et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Comparison of posaconazole and voriconazole in vitro killing against Candida krusei
Emilia Canton et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2008)
Aspergillus to zygomycetes: Causes, risk factors, prevention, and treatment of invasive fungal inections
O. A. Cornely
INFECTION (2008)
Update on the genus Trichosporon
Thomas C. Chagas-Neto et al.
MYCOPATHOLOGIA (2008)
Correlation of posaconazole minimum fungicidal concentration and time-kill test against nine Canadian species
G. Soczo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Multiple-dose pharmacokinetics and safety of the new antifungal triazole BAL4815 after intravenous infusion and oral administration of its prodrug, BAL8557, in healthy volunteers
A Schmitt-Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies
GN Mattiuzzi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Susceptibility patterns and molecular identification of Trichosporon species
JL Rodriguez-Tudela et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Microbiological characteristics of medically important Trichosporon species
HM Li et al.
MYCOPATHOLOGIA (2005)
Evaluation of the microdilution, etest and disk diffusion methods for antifungal susceptibility testing of clinical strains of Trichosporon spp.
DY Metin et al.
JOURNAL OF CHEMOTHERAPY (2005)
Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies:: a retrospective multicenter study from Italy and review of the literature
C Girmenia et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods
E Cantón et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Infections due to emerging and uncommon medically important fungal pathogens
TJ Walsh et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Patterns of amphotericin B killing kinetics against seven Candida species
E Cantón et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies
G Di Bonaventura et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species
E Cantón et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2003)
Comparison of NCCLS microdilution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolates
S Arikan et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2002)
Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods
EE Roling et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2002)
In vitro antifungal susceptibilities of Trichosporon species
NI Paphitou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Voriconazole: A new triazole antifungal
JA Sabo et al.
ANNALS OF PHARMACOTHERAPY (2000)
Share Paper
